Trial · NCT03743051
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Body Weight Over 12 Weeks | 100 mg Anamorelin HCl | 1.938 | Standard Error 0.285 | Change from baseline in body weight (kg) | |
| Mean Change From Baseline in Body Weight Over 12 Weeks | Placebo | 0.594 | Standard Error 0.285 | Change from baseline in body weight (kg) | |
| Mean Change From Baseline in 5-item Anorexia Symptom Subscale (5-IASS) Over 12 Weeks | 100 mg Anamorelin HCl | 3.816 | Standard Error 0.383 | score on a scale | |
| Mean Change From Baseline in 5-item Anorexia Symptom Subscale (5-IASS) Over 12 Weeks | Placebo | 3.194 | Standard Error 0.385 | score on a scale | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥0 kg) | 100 mg Anamorelin HCl | 9.871 | Standard Error 0.476 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥0 kg) | Placebo | 7.462 | Standard Error 0.475 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥1.5 kg) | 100 mg Anamorelin HCl | 4.967 | Standard Error 0.434 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in Body Weight (≥1.5 kg) | Placebo | 3.631 | Standard Error 0.429 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥0 Points) | 100 mg Anamorelin HCl | 10.523 | Standard Error 0.362 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥0 Points) | Placebo | 9.496 | Standard Error 0.359 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥3 Points) | 100 mg Anamorelin HCl | 6.185 | Standard Error 0.423 | Weeks | |
| Duration of Treatment Benefit (Weeks) From Baseline Over 12 Weeks in 5-IASS (≥3 Points) | Placebo | 5.650 | Standard Error 0.426 | Weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03743051/results